Literature DB >> 22188373

Autonomic dysfunction in presymptomatic spinocerebellar ataxia type-2.

J Montes-Brown1, A Machado, M Estévez, C Carricarte, L Velázquez-Pérez.   

Abstract

OBJECTIVES: To explore and quantify possible abnormalities in the autonomic cardiovascular regulation in presymptomatic stage of type 2 spinocerebellar ataxia (PS-SCA2). MATERIALS &
METHODS: Heart rate variability (HRV) for 5-min series of RR intervals was analyzed in 48 PS-SCA2. Autonomic testing included resting recording, standing, Valsalva maneuver, and deep breathing. The results were compared with a group of sex- and age-matched controls.
RESULTS: Time-and-frequency domain HRV indices were significantly different between PS-SCA2 and control groups. Using two standard diagnostic procedures were identified 4 (8.33%) subjects with severe and 8 (16.66%) subjects with early cardiac autonomic neuropathy in PS-SCA2. CAG index significantly correlated with age (-0.35) and HR (0.31).
CONCLUSIONS: Our results confirm the presence of cardiovascular autonomic dysfunction in PS-SCA2 subjects.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22188373     DOI: 10.1111/j.1600-0404.2011.01494.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Early and severe autonomic failure: broadening the clinical phenotype of type-2 spinocerebellar ataxia. A case report.

Authors:  R Capozzo; G Rizzo; M De Mari; C Tortorella; G Logroscino
Journal:  J Neurol       Date:  2014-11-20       Impact factor: 4.849

2.  Increased catabolic state in spinocerebellar ataxia type 1 patients.

Authors:  Anja Mähler; Jochen Steiniger; Matthias Endres; Friedemann Paul; Michael Boschmann; Sarah Doss
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 3.  Dilemma of multiple system atrophy and spinocerebellar ataxias.

Authors:  Ming Li; Qianqian Ma; Xing Zhao; Can Wang; Huijie Wu; Jinyao Li; Wei Yang
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

4.  Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Edilia M Cruz-Rivas; Juan Fernández-Ruiz; Israel Vaca-Palomares; Jandy Lilia-Campins; Bulmaro Cisneros; Arnoy Peña-Acosta; Yaimeé Vázquez-Mojena; Rosalinda Diaz; Jonathan J Magaña-Aguirre; Tania Cruz-Mariño; Annelié Estupiñán-Rodríguez; José M Laffita-Mesa; Rigoberto González-Piña; Nalia Canales-Ochoa; Yanetza González-Zaldivar
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

Review 5.  Cardiac involvement in hereditary ataxias.

Authors:  Sean Moore; Subha V Raman
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

6.  Autonomic function testing in spinocerebellar ataxia type 2.

Authors:  Elisabetta Indelicato; Alessandra Fanciulli; Jean Pierre Ndayisaba; Wolfgang Nachbauer; Roberta Granata; Julia Wanschitz; Michaela Wagner; Elke R Gizewski; Werner Poewe; Gregor K Wenning; Sylvia Boesch
Journal:  Clin Auton Res       Date:  2018-02-12       Impact factor: 4.435

Review 7.  Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.

Authors:  Luis C Velázquez-Pérez; Roberto Rodríguez-Labrada; Juan Fernandez-Ruiz
Journal:  Front Neurol       Date:  2017-09-11       Impact factor: 4.003

8.  Autonomic function testing in Friedreich's ataxia.

Authors:  Elisabetta Indelicato; Alessandra Fanciulli; Jean-Pierre Ndayisaba; Wolfgang Nachbauer; Andreas Eigentler; Roberta Granata; Julia Wanschitz; Werner Poewe; Gregor K Wenning; Sylvia Boesch
Journal:  J Neurol       Date:  2018-06-27       Impact factor: 4.849

Review 9.  The Multiple Faces of Spinocerebellar Ataxia type 2.

Authors:  Antonella Antenora; Carlo Rinaldi; Alessandro Roca; Chiara Pane; Maria Lieto; Francesco Saccà; Silvio Peluso; Giuseppe De Michele; Alessandro Filla
Journal:  Ann Clin Transl Neurol       Date:  2017-08-10       Impact factor: 4.511

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.